When Vertex Pharmaceuticals announced last month that its pain pill had received approval from the U.S. Food and Drug Administration (FDA), it marked a major breakthrough in the hunt for new ...

The Food and Drug Administration (FDA) recently approved a new, non-opioid (non-narcotic) prescription pill, suzetrigine (SUE ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...

Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity ... Journavx was found to be similarly effective as hydrocodone, an opioid pain medication for reducing acute pain, ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating ... found throughout the body and are particularly dense in the brain’s pain ...

During my time serving in the state legislature, I heard from numerous constituents impacted by the opioid crisis ...